(718) 670-1501 
(718) 445-9846PUBLICATIONS
- Carotid and Soft Tissue Tolerance in Rabbit to Low Dose Rate (LDR) Weber, J., Sood, B.M., et al: Interstitial Brachytherapy, acute Effects-I Brachytherapy, Laryngoscope, June, 1991, 101: 5487-591.
- Pilot study evaluating Nicotinamide in metastatis brain tumors treated with radiation Pisch, J., Sood, B.M., et al: Radiation Oncology Investigation, 1994, 1:292-296.
- Letter to the editor. Dosimetric considerations in perenial template: Regarding Kavanagh, Deore, S., Sood, B.M., et al. IJROBP, 1995 30:555 Vol. 32.
- Dosimetric and dose-fractionation concerns in vaginal cuff irradiation using dose rate brachytherapy: regarding Noyes et al. S. Deore, D. Fontenla, M. Ahmad , E. Mullokandov, Sood, B.M., B. Vikram . IJROBP., 1995, 32(5):1439-1443;.
- On line in-vivo dosimetry for intracavitary HDR brachytherapy using MOSFET dosimetry system, Sood, B.M., Deore, S.M., Fontenla, D.P., Vikram, B., Radiother Oncol., 40, 1996, pp106.
- Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherpay for locally advanced squamous cell carcinoma of the cervix. A. Fields, P. Anderson, G. Goldberg, S. Wadler, J. Beitler, Sood, B.M., C. Runowicz . Gynecologic Oncology 1996, Vol. 61, Pages 416-422.
- The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix. S. Wadler, G. Goldberg, A. Fields, P. Anderson, J. Beitler, Sood, B.M., H. Haynes, C. Runowicz . Semin Oncol. 1996 Aug;23(4 Suppl 8):64-8. Review.
- Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival? Beitler JJ, Anderson PS, Wadler S., Runowicz CD, Hayes MK, Fields AL, Sood, B.M., Goldberg GL. Int J Radiat Onccol Biol Phys.
1997 Apr 1;38(1):43-8.
- A novel second line chemotherapy treatment of recurrent thymoma. Jan N., Villani GM, Trambert J, Fehmian C.,
Sood, B.M., Wiernik PH., Medical Oncology 1997, Sept-Dec 14 (3-4):163-8.
- The relationship between dose heterogeneity ("hot" spots) and complications following high dose rate brachytherapy. Vikram B., Deore S., Beitler JJ, Sood, B.M., Mullokandov E., Kapulsky A., Fontenla DP. Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):983-7.
- Accelerated regression of brain metastases in patients receiving whole brain radiation and the topoisomerase II inhibitor, lucanthone. Del Rowe JD, Bello J., Mitnick R., Sood, B.M., Filippi C., Moran J., Freeman K., Mendez F., Bases R. Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):89-93.
- High dose rate brachytherapy in patients with previously untreated cancers of the head and neck. Vikram, B., Beitler, J.B., Sood, B.M., Deore, S.M., Fontenla, D.P. - Journal of Brachytherapy International - 16, 95-101. 2000.
- Two fractions of high-dose-rate brachytherapy in the management
of cervix cancer: Clinical experience with and without chemotherapy. Sood, B.M., Gorla, G., Gupta, S., et al. Int. J. Radiation Oncology Biol. Phys. 2002 Vol. 53, No. 3, pp. 702-706.
- Concomitant cisplatin and extended field radiation therapy in
patients with cervical and endometrial cancer. Sood, B.M., Timmins, P.F., Gorla, G.R., et al. Int. J. Gynecol Cancer 2002, Vol. 12 pp. 459-464.
- Extended-field radiotherapy and high-dose-rate brachytherapy in
carcinoma of the uterine cervix. Clinical experience with and without concomitant chemotherapy. Sood, B.M., Gorla, G.R., Garg, M., et al. Cancer 2003;97:1781-8
- Predictive value of linear-quadratic model in the treatment of cervical cancer using high-dose-rate brachytherapy. Sood, B.M., Garg, M., Avadhani, J., et al. Int. J. Radiation Oncology Biol. Phys. 2002 Vol. 54, No. 5, pp1377 -1387.
- Microsatellite dinucleotide (t-g) repeat: a candidate dna marker for breast metastasis. Mukherjee, B., Zhao, H., Parashar, B., Sood, B.M., et al. Cancer Detection and Prevention 27 (2003) pp. 19-23.
- Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Sood, B.M., Jones, J., Gupta, S., et al. Int. J. Radiation Oncology Biol. Phys., 2003, Vol. 57, No. 1, pp. 208-216.
SCIENTIFIC PRESENTATIONS
EXTRAMURAL
- "Partial Hemipelvectomy and Excision of Ilium in Moderately Advanced Malignancy of Pelvis" Annual Meeting of the Association of the Surgeons. Sood, B.M. , India, December 1981
- "Combined Modalities of Treatment in Advanced Malignancy of Ovary" Annual Meeting of Federation of Society of Gynecology. Sood, B.M., India, December 1981.
- Modulation of natural killer (NK) cell activity by Radiation therapy and its impact on prognosis. Sood, B.M.,Chadha, M. et al Proceedings RSNA 1989 Chicago.
- "Technical and Logistic Considerations for Endobronchial Brachytherapy" - Fine, R., Sood, B.M. et al: Presented at the International Conferences on Advances in Brachytherapy, June 1992, New York.
- "Gynecological Radiation Oncology and Update", Gynecology Grand Rounds, Sood, B.M., The Genesee Hospital, Rochester, NY, August 2, 1992.
- Radiation therapy in acquired immune deficiency syndrome (AIDS) patients with cervical cancer. Chada, M., Sood, B.M. etal: Proceedings, ASTRO 1994.
- Vaginal apex recurrence in patients with early endometrial carcinoma treated by post operative external radiotherapy without intravaginal boost. G. Gejerman, Katz, A., J. Beitler, W. Sandra, Sood, B.M. et al: Proceedings of ASTRO 1994.
- Pelvic Excentration for Recurrent Cervical Cancer: would improve local control, improve survival. J. Beitler, P. Anderson, C. Runowicz, A. Fields, Sood, B.M. et al: Proceeding, SGO 1995.
- Syed Template (Ca Cervix) dosimetric considerations, Sood, B.M.,
S. Deore, et al: Proceedings ECHO, 1995.
- On line in vivo dosimetry for intracavitary HDR Brachytherapy using MOSFET dosimetry system. Sood, B.M., Proceedings ESTRO, 1996.
- Concomitant Cisplatin (CDDP) and Extended Field Radiation Therapy (EFRT) in Cervical and Endometrial Cancer. Sood, B.M., et al, Proceedings SGO 99, San Francisco, Abstract #70.
- Patterns of Failure in Uterine Papillarry Serous Carcinoma (UPSC) Suggest a Role for Whole Abdomen Radiation Therapy (RT) and Intravaginal Boost. Sood, B.M., et al: - Albert Einstein College of Medicine, Bronx, NY, USA, Proceedings ASTRO99, New Orleans, Abstract #2171.
- Is it necessary to use more than two fractions of high dose rate brachytherapy (HDRBT) in the treatment of patients with carcinoma of cervix: Prelimary results. Sood, B.M., et al: Proceeding American Radium Society, 99., Hawaii.
- Matched Pair Analysis of Low Dose Rate Brachytherapy (LDRBT) Versus 2 Fractions (Fx.) of high Dose Rate Brachytherapy (HDRBT) for carcinoma Cervix (Ca. Cx.) Sood, B.M., et al - Abstract, ESTRO Proceeding London, 2000.
- Toxicity Profile of Cisplatin (CDDP) with Extended-Field Radiotherapy (EFRT) and High Dose Rate Brachytherapy (HDRBT) for Locally Advanced Carcinoma of the Cervix (CACX). Sood, B.M., et al - Proceedings ASCO, San Diego, 2000. Abstract # 1540.
- HER - 2/neu Expression in Uterine Papillary Serous Carcinoma (UPSC): Association with Risk Factors and Survival -Feb. 2000. T. McElrath, E. Naar, Sood, B.M., et al . Society of Gynecologic Oncologists, San Diego, SG0 2000, Abstract # 172.
- An Independent Technique for Verifying Planned Overall Treatment Times in Single Catheter and Cervix HDR Brachytherapy. R. Yaparpalvi, S. Deore, Sood, B.M., et al. Submitted ASTRO, 2001.
- Influence of Ovoid Shields and Geometry of Insertion on Doses to Critical Structures in Fletcher-Suit Intracavitary Application. S. Deore, R. Yaparpalvi, Sood, B.M., et al. Submitted AAPM, Salt Lake City, July 2001.
INTRAMURAL
- "Advantages of Hypothenar Skin Graft versus Split Thickness Skin Graft in Traumatic Hand (Pulp) Injuries", 1979 M.G.M. Hospital, Bombay, India.
- "Role of Prophylactic Metroniadazole in Reconstructive Surgery of Head and Neck", 1982. Tata Memorial Cancer Center, Bombay, India.
- Post-Doctoral Thesis for M.S. General Surgery - (Bombay Universioty, Bombay India 1983) "Retrospective Analysis and Follow-up of Carcinoma Colon" Tata Memorial Cancer Center, (1972-1975), Bombay, India.
- "Hodgkins Disease in Children", Review of 157 cases (1970-1986) at memorial Sloan Kettering Cancer Center - 1986, NY 10020.
- "Venous Access Catheters in Children", (1986-1987), An experience at Memorial Sloan Kettering Cancer Center - 1987, NY 10020.
- "Retrospective Analysis of Surgical Stage T1/T2/Nx Mo Breast Carcinoma Treated with Lumpectomy and Local External Radiotherapy", an Institutions Experience (1990) Beth Israel Medical Center, NY 10003
- "Preoperative Intracavitary Therapy in Stage I Carcinoma of the Endometrium", and Institutions Experience (1990) Beth Israel Medical Center, NY 10003
- Determination of ERCC1 and C-RAF-1 proto-oncogene levels in patients undergoing combined cisplatin and radiation therapy or radiation therapy only for inoperable squamous cell carcinoma of the uterine cervix. Sood, B.M., et al. Proceedings - Radiation Oncology Research Retreat, New York Botanical Gardens, May, 1995.
- Radiation heptopathy in the Rat. C. Guha, Sood, B.M., etal. Proceedings Radiation Oncology Research Retreat, New York Botanical Gardens May, 1995.
- "Role of Brachytherapy in Cancer Management" Grand Rounds, Radiation oncology, Roswell Park Cancer Institute, Buffalo, NY, January 23, 1993.
- External Radiotherapy Technique for Prostate Cancer using State of the Art Technology, February 1993. Grand Rounds, the Genesee Hospital, Rochester, NY.
- "Intraoperative Elective Brachytherapy and the Concept of a
Dedicated Brachytherapy Center", Grand Rounds, Radiation Oncology Strong Memorial Hospital, University of Rochester, Rochester, NY, April 1993.
Back to Top